Status:
UNKNOWN
Automate Music Therapy for the Management of Behavioral Disorders in Nursing Homes
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Alzheimer Disease
Major Neurocognitive Disorder
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Alzheimer disease is the most common neurodegenerative brain disease that causes cognitive impairment in the elderly but also behavioral and psychological symptoms. Among these symptoms, agitation is ...
Eligibility Criteria
Inclusion
- Age ≥ 60 years old
- Male or Female
- Patients with a diagnosis of Alzheimer disease according to the criteria of NINCDS-ADRDA or typical or atypical Alzheimer disease
- MMSE \< 20
- Patient residing in nursing home
- Voluntary, written and informed consent of the patient himself or its legal representative (guardian/curator)
- Affiliation to a social security system
Exclusion
- Prescription of a new psychotropic treatment (hypnotic, anxiolytic, antidepressant, antipsychotic) in week prior to the evaluation
- Hearing loss preventing the patient from responding perfectly to the therapeutic solutions provided
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04327778
Start Date
April 1 2020
End Date
August 1 2021
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France